H L McLeod|M V Relling - JoVE Visualize

Showing results (71-80 of 281) with videos related to

Pageof 29

Sort By:

International Journal of Oncology|July 11, 2001

Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancerS Marsh, J A McKay, J Cassidy, et al.

Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 1997

High-performance liquid chromatographic assay of 5-fluorouracil in human erythrocytes, plasma and whole bloodW Wattanatorn, H L McLeod, J Cassidy, et al.

Journal of the National Cancer Institute|December 18, 1996

Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposideC L Chen, J C Fuscoe, Q Liu, et al.

Molecular Pharmacology|February 1, 1994

O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4M V Relling, J Nemec, E G Schuetz, et al.

Clinical Pharmacology and Therapeutics|June 1, 1987

Simultaneous administration of multiple model substrates to assess hepatic drug clearanceW R Crom, S L Webster, L Bobo, et al.

Clinical Pharmacology and Therapeutics|May 1, 1989

Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in childrenW E Evans, M V Relling, W P Petros, et al.

Journal of Immunological Methods|May 24, 2000

ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemiaB Wang, L J Hak, M V Relling, et al.

Annals of Hematology|May 6, 2004

Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemiaC H Pui, M V Relling, J T Sandlund, et al.

Cancer Research|August 2, 2001

Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cellsT Dervieux, J G Blanco, E Y Krynetski, et al.

Clinical Pharmacology and Therapeutics|September 1, 1991

Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjectsM V Relling, J Cherrie, M J Schell, et al.

Pageof 29

Showing results (71-80 of 281) with videos related to

Sort By:

Pageof 29

International Journal of Oncology|July 11, 2001

Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancerS Marsh, J A McKay, J Cassidy, et al.

Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 1997

High-performance liquid chromatographic assay of 5-fluorouracil in human erythrocytes, plasma and whole bloodW Wattanatorn, H L McLeod, J Cassidy, et al.

Journal of the National Cancer Institute|December 18, 1996

Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposideC L Chen, J C Fuscoe, Q Liu, et al.

Molecular Pharmacology|February 1, 1994

O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4M V Relling, J Nemec, E G Schuetz, et al.

Clinical Pharmacology and Therapeutics|June 1, 1987

Simultaneous administration of multiple model substrates to assess hepatic drug clearanceW R Crom, S L Webster, L Bobo, et al.

Clinical Pharmacology and Therapeutics|May 1, 1989

Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in childrenW E Evans, M V Relling, W P Petros, et al.

Journal of Immunological Methods|May 24, 2000

ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemiaB Wang, L J Hak, M V Relling, et al.

Annals of Hematology|May 6, 2004

Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemiaC H Pui, M V Relling, J T Sandlund, et al.

Cancer Research|August 2, 2001

Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cellsT Dervieux, J G Blanco, E Y Krynetski, et al.

Clinical Pharmacology and Therapeutics|September 1, 1991

Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjectsM V Relling, J Cherrie, M J Schell, et al.

Pageof 29